MiNK Therapeutics, Inc. (NASDAQ:INKT) Sees Large Decline in Short Interest
MiNK Therapeutics, Inc. (NASDAQ:INKT – Get Free Report) was the recipient of a significant decline in short interest in June. As of June 15th, there was short interest totalling 117,600 shares, a decline of 31.3% from the May 31st total of 171,300 shares. Currently, 2.2% of the shares of the stock are short sold. Based […]
More Stories
Oppenheimer & Co. Inc. Has $855,000 Position in SPDR Bloomberg High Yield Bond ETF (NYSEARCA:JNK)
Oppenheimer & Co. Inc. cut its stake in shares of SPDR Bloomberg High Yield Bond ETF (NYSEARCA:JNK – Free Report)...
BlackRock Capital Allocation Term Trust (NYSE:BCAT) Shares Bought by Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. lifted its stake in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by...
Oppenheimer & Co. Inc. Has $1.04 Million Stake in Sprouts Farmers Market, Inc. (NASDAQ:SFM)
Oppenheimer & Co. Inc. trimmed its holdings in shares of Sprouts Farmers Market, Inc. (NASDAQ:SFM – Free Report) by 7.0%...
Oppenheimer & Co. Inc. Buys Shares of 10,052 SPDR S&P Homebuilders ETF (NYSEARCA:XHB)
Oppenheimer & Co. Inc. purchased a new position in SPDR S&P Homebuilders ETF (NYSEARCA:XHB – Free Report) during the first...
Oppenheimer & Co. Inc. Trims Stock Holdings in Invesco Water Resources ETF (NASDAQ:PHO)
Oppenheimer & Co. Inc. reduced its position in Invesco Water Resources ETF (NASDAQ:PHO – Free Report) by 2.2% in the...
KANZHUN LIMITED Sponsored ADR (NASDAQ:BZ) Position Lifted by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. raised its stake in KANZHUN LIMITED Sponsored ADR (NASDAQ:BZ – Free Report) by 42.2% in the...